Facial Paralysis
Facial nerve loss of motion has numerous causes and can be intense or incessant. Understanding the signs and side effects, playing out a cautious patient assessment, and acquiring suitable indicative testing can help manage clinicians and improve results. Idiopathic facial loss of motion, otherwise called Bell's paralysis, is the most widely recognized type of facial loss of motion, representing 60 to 75% of cases. This condition influences the seventh cranial nerve and is described by intense, one-sided beginning that bargains capacity and style, applying an extensive effect on the social, proficient, and mental parts of the lives of influenced people.
High Impact List of Articles
-
Current strategies for bridging dual antiplatelet therapy in patients requiring surgery
I Anastasiou, S Petousis & M Hamilos
Review Article: Interventional Cardiology
-
Current strategies for bridging dual antiplatelet therapy in patients requiring surgery
I Anastasiou, S Petousis & M Hamilos
Review Article: Interventional Cardiology
-
New evidence for gender disparities in cardiac interventions: CREATE-ing some clarity
A Sigamani, D Kamath, D Xavier & P Pais
Editorial: Interventional Cardiology
-
New evidence for gender disparities in cardiac interventions: CREATE-ing some clarity
A Sigamani, D Kamath, D Xavier & P Pais
Editorial: Interventional Cardiology
-
Selecting the optimal closure device in patients with atrial septal defects and patent foramen ovale
D Roy, R Sharma, N Bunce, D Ward & SJ Brecker
Review Article: Interventional Cardiology
-
Selecting the optimal closure device in patients with atrial septal defects and patent foramen ovale
D Roy, R Sharma, N Bunce, D Ward & SJ Brecker
Review Article: Interventional Cardiology
-
Choice of stent in iliac occlusive disease
D Vandeweyer, J Verbist, M Bosiers, K Deloose & P Peeters
Review Article: Interventional Cardiology
-
Choice of stent in iliac occlusive disease
D Vandeweyer, J Verbist, M Bosiers, K Deloose & P Peeters
Review Article: Interventional Cardiology
-
Biodegradable polymer limuseluting stents are noninferior to permanent polymer-based stents: the ISAR-TEST-4 trial
RA Byrne & A Kastrati
Short Article: Interventional Cardiology
-
Biodegradable polymer limuseluting stents are noninferior to permanent polymer-based stents: the ISAR-TEST-4 trial
RA Byrne & A Kastrati
Short Article: Interventional Cardiology
Relevant Topics in Clinical